Literature DB >> 8399191

Actin-dystrophin interface.

E Fabbrizio1, A Bonet-Kerrache, J J Leger, D Mornet.   

Abstract

Dystrophin, an elongated cytoskeletal molecule which is deficient in Duchenne muscular disease, contains an actin-binding domain in its N-terminal portion. We show that this part interacted with actin in the native molecule. By molecular biology techniques, four recombinant proteins were expressed in Escherichia coli using the pMAL vector which allowed us to obtain soluble proteins directly after purification. These constructions were tested for their ability to bind actin under various conditions, and their apparent dissociation constants were determined. The effects of other actin-binding proteins such as caldesmon and tropomyosin were analyzed in comparison to the actin-binding properties of these constructions. These results support the potential concept of a multiple actin-binding contact in the N-terminal region of dystrophin. Differences in the functional domains are discussed relative to similar alpha-actinin-actin-binding sites.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399191     DOI: 10.1021/bi00090a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and protein aggregation.

Authors:  Davin M Henderson; Ann Lee; James M Ervasti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

Review 2.  Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Authors:  Jane T Seto; Julian N Ramos; Lindsey Muir; Jeffrey S Chamberlain; Guy L Odom
Journal:  Curr Gene Ther       Date:  2012-06       Impact factor: 4.391

3.  Expression of dystrophins and the dystrophin-associated-protein complex by pituicytes in culture.

Authors:  Abdelkader Bougrid; Thomas Claudepierre; Serge Picaud; Ghazi Ayad; Dominique Mornet; Latifa Dorbani-Mamine; Alvaro Rendon; Halima Darbeida
Journal:  Neurochem Res       Date:  2011-04-12       Impact factor: 3.996

Review 4.  The membrane-cytoskeleton interface: the role of dystrophin and utrophin.

Authors:  S J Winder
Journal:  J Muscle Res Cell Motil       Date:  1997-12       Impact factor: 2.698

5.  Actin interaction with purified dystrophin from electric organ of Torpedo marmorata: possible resemblance with filamin-actin interface.

Authors:  M C Lebart; D Casanova; Y Benyamin
Journal:  J Muscle Res Cell Motil       Date:  1995-10       Impact factor: 2.698

Review 6.  The dystrophin superfamily: variability and complexity.

Authors:  E Fabbrizio; F Pons; A Robert; G Hugon; A Bonet-Kerrache; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

7.  In situ molecular association of dystrophin with actin revealed by sensitized emission immuno-resonance energy transfer.

Authors:  D D Root
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

8.  Crystal structure of the actin-binding domain of alpha-actinin-4 Lys255Glu mutant implicated in focal segmental glomerulosclerosis.

Authors:  Sung Haeng Lee; Astrid Weins; David B Hayes; Martin R Pollak; Roberto Dominguez
Journal:  J Mol Biol       Date:  2007-12-04       Impact factor: 5.469

9.  The 3D structure of villin as an unusual F-Actin crosslinker.

Authors:  Cheri M Hampton; Jun Liu; Dianne W Taylor; David J DeRosier; Kenneth A Taylor
Journal:  Structure       Date:  2008-12-10       Impact factor: 5.006

10.  Mutations in the gamma-actin gene (ACTG1) are associated with dominant progressive deafness (DFNA20/26).

Authors:  M Zhu; T Yang; S Wei; A T DeWan; R J Morell; J L Elfenbein; R A Fisher; S M Leal; R J H Smith; K H Friderici
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.